Conclusion Long-term administration of VASOREL has favorable clinical tolerability and safety for CHD patients.
结论冠心病患者长期服用曲美他嗪的临床耐受性和安全性良好。
2
Results the trial was completed in 95% of the patients, 2 patients withdrew in the VASOREL group and 4 patients in the control group; but none for the intolerable therapy.